文献速递眼底病与葡萄膜炎

玻璃体切除术联合完全引流脉络膜上腔积液且围手术期不用激素治疗孔源性视网膜脱离合并脉络膜脱离:一项随机临床试验

VITRECTOMY AND COMPLETE DRAINAGE OF SUPRACHOROIDAL FLUID WITHOUT PERIOPERATIVE STEROIDS FOR RHEGMATOGENOUS RETINAL DETACHMENT COMBINED WITH CHOROIDAL DETACHMENT: A Randomized Clinical Trial.
PubMed 文献 · Retina · 2025-01-01

这项前瞻性随机对照试验将58只孔源性视网膜脱离合并脉络膜脱离眼随机分为无激素组和局部激素组,每组29眼。无激素组在玻璃体切除术前完全引流脉络膜上腔积液,局部激素组术前接受单次眶周注射甲泼尼龙。两组视网膜复位率、视力改善、炎症、低眼压及黄斑脉络膜皱褶发生率均无显著差异,结论认为术前完全引流积液时术前激素可能并非必要。

要点

  • 无激素组与局部激素组术后视网膜复位率分别为96.6%与93.1%,差异无统计学意义(P=1.00)。
  • 无激素组与局部激素组最佳矫正视力改善比例分别为72.4%与75.9%。
  • 低眼压和黄斑脉络膜皱褶在术后1周消失,两组炎症、低眼压及皱褶发生率均无显著差异。

核心结论

  • 若玻璃体切除术前完全引流脉络膜上腔积液,孔源性视网膜脱离合并脉络膜脱离患者可能不需要术前激素。
  • 术后视网膜复位不依赖术前激素的使用;作者认为术者应聚焦于改进孔源性视网膜脱离合并脉络膜脱离的手术技术以提高视网膜复位率。

研究设计与样本

  • 前瞻性随机对照试验,共纳入58只眼,随机分为无激素组和局部激素组,每组29眼。
  • 局部激素组术前接受单次眶周注射甲泼尼龙;无激素组在玻璃体切除术前进行脉络膜上腔积液引流。
  • 术后随访评估时间为术后1周、1个月、3个月和6个月。

主要发现

  • 无激素组与局部激素组术后视网膜复位率分别为96.6%与93.1%,差异无统计学意义(P=1.00)。
  • 无激素组与局部激素组最佳矫正视力改善比例分别为72.4%与75.9%。
  • 无激素组炎症发生5眼(17.2%),局部激素组6眼(20.7%),差异无统计学意义(P=0.74)。
  • 低眼压发生在局部激素组11眼(37.9%)与无激素组14眼(48.3%),差异无统计学意义(P=0.43)。
  • 黄斑脉络膜皱褶见于局部激素组21眼(72.4%)与无激素组22眼(75.9%),差异无统计学意义(P=0.76)。

临床怎么用

  • 作者认为,若玻璃体切除术前完全引流脉络膜上腔积液,孔源性视网膜脱离合并脉络膜脱离患者可能不需要术前激素。
  • 作者认为,术后视网膜复位不依赖术前激素的使用,术者应聚焦于改进手术技术以提高视网膜复位率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the surgical effect of complete drainage of suprachoroidal fluid before vitrectomy to avoid perioperative steroids in rhegmatogenous retinal detachment combined with choroidal detachment eyes. METHODS: It was a prospective, randomized controlled trial. Fifty-eight eyes were randomly divided into the no steroids (NS) group and local steroids (LS) group, 29 eyes each, respectively. Patients in the LS group received a single preoperative periocular injection of methylprednisolone, while suprachoroidal fluid drainage was performed before vitrectomy in eyes of the NS group. Follow-up assessments were performed at 1 week, 1 month, 3 months, and 6 months postoperatively. RESULTS: The postoperative retinal reattachment rate was similar in the NS and LS groups (96.6% vs. 93.1%, P = 1.00). Best-corrected visual acuity was improved in 72.4% and 75.9% in the NS and LS groups, respectively. Inflammation occurred in five eyes (17.2%) in the NS group and six eyes (20.7%) in the LS group ( P = 0.74). Hypotony occurred in 11 (37.9%) and 14 eyes (48.3%) in the LS and NS groups ( P = 0.43), respectively. Macular chorioretinal folds were found in 21 (72.4%) and 22 eyes (75.9%) in the LS and NS groups ( P = 0.76), respectively. Hypotony and chorioretinal folds disappeared after 1 week postoperatively. CONCLUSION: Preoperative steroids may not be necessary for rhegmatogenous retinal detachment combined with choroidal detachment patients if the suprachoroidal fluid is completely drained before vitrectomy. Postoperative retinal reattachment does not depend on the use of preoperative steroids; instead, surgeons should focus on improving surgical techniques in rhegmatogenous retinal detachment combined with choroidal detachment to improve the retinal reattachment rate.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Lin W, Chen H, Ren M, et al. VITRECTOMY AND COMPLETE DRAINAGE OF SUPRACHOROIDAL FLUID WITHOUT PERIOPERATIVE STEROIDS FOR RHEGMATOGENOUS RETINAL DETACHMENT COMBINED WITH CHOROIDAL DETACHMENT: A Randomized Clinical Trial. Retina. 2025. PMID: 39693571. doi:10.1097/IAE.0000000000004374

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。